Application

REPTYROS

Turning Point Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97272831
Filing Date: 02/17/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97272831
MARK INFORMATION
*MARK REPTYROS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT REPTYROS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Turning Point Therapeutics, Inc.
*MAILING ADDRESS 10628 Science Center Drive, Suite 200
*CITY San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of cancer
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 084125
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Jamaica
       FOREIGN FILING DATE 08/20/2021
       INTENT TO
       PERFECT 44(d)
At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis for registration, but is only asserting a valid claim of priority.
ATTORNEY INFORMATION
NAME John Paul Oleksiuk
ATTORNEY DOCKET NUMBER 321172-20000
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
STREET 1299 PENNSYLVANIA AVENUE, NW, SUITE 700
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20004-2400
EMAIL ADDRESS trademarks@cooley.com
OTHER APPOINTED ATTORNEY Susan Piascik Christoff, Brian Focarino, Bobby A. Ghajar, Colette A. Ghazarian, Rebecca Givner-Forbes, Kelley B. Harrington, Shannan Higgins, Ariana G. Hiscott, Brendan J. Hughes, Judd D. Lauter, Anne H. Peck, Marcus D. Peterson, Elisa Rosen, Elizabeth F. Reinhardt, Dina Roumiantseva, Jane van Benten, Colleen Wellington-Caban and Jessica M. Williams
CORRESPONDENCE INFORMATION
NAME John Paul Oleksiuk
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@cooley.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /Paolo Tombesi/
SIGNATORY'S NAME Paolo Tombesi
SIGNATORY'S POSITION Executive Vice President, Chief Financial Officer
SIGNATORY'S PHONE NUMBER 202-842-7800
DATE SIGNED 02/17/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97272831
Filing Date: 02/17/2022

To the Commissioner for Trademarks:

MARK: REPTYROS (Standard Characters, see mark)
The literal element of the mark consists of REPTYROS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Turning Point Therapeutics, Inc., a corporation of Delaware, having an address of
      10628 Science Center Drive, Suite 200
      San Diego, California 92121
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of cancer
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Jamaica application number 084125, filed 08/20/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis for registration, but is only asserting a valid claim of priority.




The owner's/holder's proposed attorney information: John Paul Oleksiuk. Other appointed attorneys are Susan Piascik Christoff, Brian Focarino, Bobby A. Ghajar, Colette A. Ghazarian, Rebecca Givner-Forbes, Kelley B. Harrington, Shannan Higgins, Ariana G. Hiscott, Brendan J. Hughes, Judd D. Lauter, Anne H. Peck, Marcus D. Peterson, Elisa Rosen, Elizabeth F. Reinhardt, Dina Roumiantseva, Jane van Benten, Colleen Wellington-Caban and Jessica M. Williams. John Paul Oleksiuk, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1299 PENNSYLVANIA AVENUE, NW, SUITE 700
      Washington, District of Columbia 20004-2400
      United States
      trademarks@cooley.com
The docket/reference number is 321172-20000.
John Paul Oleksiuk submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      John Paul Oleksiuk
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cooley.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Paolo Tombesi/   Date: 02/17/2022
Signatory's Name: Paolo Tombesi
Signatory's Position: Executive Vice President, Chief Financial Officer
Signatory's Phone Number: 202-842-7800
Signature method: Sent to third party for signature
Payment Sale Number: 97272831
Payment Accounting Date: 02/17/2022

Serial Number: 97272831
Internet Transmission Date: Thu Feb 17 20:08:05 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XXX-2022021720080514
9179-97272831-8105c752d1331b21f941670dc7
357d9fe8cf755fd49b0e0a95330ea9665e4d8426
-DA-08044551-20220217092048538168

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed